CNR1 and obesity due to melanocortin 4 receptor deficiency: Moreover, these findings indicate that CNR1 gene antagonists improve glucose and lipid homeostasis, which occurs independently of weight loss, implying that CNR1 gene variability may contribute to obesity-related metabolic disorders in view of human obesity.